McNamara Tapped to Lead Commercial Organization as Demand Increases for Apixio’s Artificial Intelligence Solutions
SAN MATEO, Calif., July 22, 2019 — Apixio Inc., the AI healthcare analytics company, today announced it has promoted Tom McNamara to the role of Chief Growth Officer. In this new role, McNamara will lead the integration and expansion of Apixio’s commercial organization including sales, account management, sales operations, and marketing to position the company for its next phase of accelerated growth.
The move comes amid growing demand for Apixio’s healthcare solutions, which leverage artificial intelligence to transform disparate data into actionable knowledge. Apixio’s solutions empower health plans and providers to mine unstructured clinical data for key insights to manage risk and quality programs more effectively. These powerful capabilities position Apixio as a market leader in the burgeoning multi-billion dollar AI market.
Over the last three years, Apixio has substantially grown its nationwide customer base, expected to reach fifty health plans and provider groups by the end of 2019. The company’s sales and marketing team has doubled to meet increasing demand. In McNamara’s new role, he will closely partner with Apixio’s Chief Marketing Officer, Mark Scott, and his team to bring more sophisticated products to market quickly. Under this new direction, Scott’s role will expand to include leadership of the company’s product marketing strategy.
“The tighter integration of marketing and sales strategies under Tom’s leadership will help us partner with a greater number of payers and providers to offer them transformative AI solutions for value-based care,” said Apixio CEO Darren Schulte, MD. “Tom’s deep industry expertise and track-record in guiding companies to success is exactly the kind of experience we need to realize Apixio’s full potential.”
McNamara has spent the last 25 years building successful commercial teams for healthcare technology and analytics companies, including his last three years as Chief Revenue Officer at Apixio. Previously, he served as head of sales for GNS Healthcare, Connance, Silverlink Communications, and HPR, where he helped lead a successful IPO and acquisition.
“With Apixio’s robust and proven technology, we have a real opportunity to solidify our role as the leader in healthcare AI at a pivotal time in the industry,” McNamara said. “Aligning our expansion plans with an aggressive product roadmap under this new commercial organization enables us to support our growing customer base while also ramping up innovation to solve some of the biggest challenges in healthcare data today and in the future.”
To learn more about Apixio’s AI-driven healthcare analytics platform, visit www.apixio.com.
Improving healthcare outcomes requires access to the right data at the right time. Apixio is advancing value-based care with data-driven intelligence and analytics. Our AI solutions for risk, quality, and clinical insights unlock actionable information from administrative data and unstructured clinical information. The results drive better clinical decision-making and a smarter approach to healthcare. Learn more at www.apixio.com.
# # # # #